Real World Health Care recently sat down with Dr. Razelle Kurzrock, Director, Center for Personalized Cancer Therapy & Clinical Trials Office, University of California San Diego Moores Cancer Center, to discuss the present state and future direction of genomics and immunotherapy. Real World Health Care: Why was the Center for…more.
- RWHC Home
- About RWHC
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Behavioral Health
- Movement Disorders
- Big Data
- Multiple Myeloma
- CAR-T Cell Therapy
- Non-Small Cell Lung Cancer
- Nonalcoholic Steatohepatitis
- COVID 19
- Pain Management
- Hepatitis C
- Personalized Medicine
- Secondary Progressive MS
- Macular Degeneration
Personalized Medicine & Companion Diagnostics: Speaking with Keith Stewart, Director of the Mayo Clinic Center for Individualized Medicine
Editor’s Note: This week, we sit down with Keith Stewart, director of the Mayo Clinic Center for Individualized Medicine. Real World Health Care: Why was the Center for Individualized Medicine formed at the Mayo Clinic? What were its initial goals and how have those goals changed? Keith Stewart: The Center…more.
Editor’s Note: Based on an article originally published in Biotech Primer Weekly. Hearing your doctor utter the words HER2-positive, HR-positive, triple-negative or BRCA mutation can be devastating — even for the most resilient person. Simply put, all are linked to breast cancer. Breast cancer is complex, and a diagnosis can…more.
Personalized Medicine & Companion Diagnostics: Speaking with Dr. Joshua Cohen, Tufts Center for the Study of Drug Development
Editor’s Note: In August, the Tufts Center for the Study of Drug Development (CSDD) hosted a roundtable of R&D leaders focused on development of companion diagnostics that can show their use in conjunction with personalized therapeutics that will lead to positive health outcomes. We spoke with Joshua P. Cohen, Ph.D.,…more.
Personalized medicine – also referred to as precision or stratified medicine – is already changing the way we diagnose and treat disease. As our ability to obtain and analyze large amounts of genetic data increases, so too will the range and power of these personalized tools. The idea of personalized…more.
For more than two years, the staff of and contributors to www.RealWorldHealthCare.org (RWHC) have been proud to share stories about proven healthcare solutions that lower costs, improve access to care, and lead to better patient outcomes. Starting this Fall, RWHC will embark on a new mission. Each quarter, we will…more.
What cancer patient would want to use trial and error with various chemotherapies when he or she could know first from a diagnostic that one agent in particular would result in the most successful outcome? A new field has emerged, companion diagnostics, to help predict a patient’s compatibility with chemotherapy or…more.